Direct Comparison of FDG PET and CT Findings in Patients with Lymphoma: Initial Experience
作者： Mitsuaki Tatsumi , Christian Cohade , Yuji Nakamoto , Elliot K. Fishman , Richard L. Wahl
DOI: 10.1148/RADIOL.2373040555
关键词:
摘要: PURPOSE: To retrospectively compare fluorine 18 fluorodeoxyglucose (FDG) positron emission tomographic (PET) and computed (CT) findings at the same anatomic locations in patients with lymphoma by using a combined PET/CT scanner to analyze lesions on metabolic bases evaluate causes of discrepant between two modalities. MATERIALS AND METHODS: The institutional review board allowed an exempt retrospective cancer PET database, informed consent was waived. study HIPAA compliant. Fifty-three (20 Hodgkin 33 non-Hodgkin; mean age, 43 years; range, 12–83 years) who underwent FDG were included. CT images interpreted nuclear medicine physicians one radiologist, respectively, blinded other imaging findings. Concordant regarded as positive or negative for lymphoma. site discordant defined disease if it accompanied ...
rsna.org
elsevier.com
rsnajnls.org参考文章(22)
Christoph Nerl, Christoph Fuchs, Sibylle Ziegler, Markus Schwaiger, Wolfgang Römer, Axel-R. Hanauske, Wolfgang Weber, Ralf Thödtmann, Manfred Garbrecht, Wolfgang Enne, Michael Herz, Positron Emission Tomography in Non-Hodgkin's Lymphoma: Assessment of Chemotherapy With Fluorodeoxyglucose Blood. ,vol. 91, pp. 4464- 4471 ,(1998) , 10.1182/BLOOD.V91.12.4464
G. Jerusalem, Y. Beguin, M.F. Fassotte, F. Najjar, P. Paulus, P. Rigo, G. Fillet, Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood. ,vol. 94, pp. 429- 433 ,(1999) , 10.1182/BLOOD.V94.2.429
Dominique Delbeke, Oncological Applications of FDG PET Imaging: Brain Tumors, Colorectal Cancer Lymphoma and Melanoma The Journal of Nuclear Medicine. ,vol. 40, pp. 591- 603 ,(1999)
Zohar Keidar, Abraham Kuten, Ludmila Guralnik, Nikolai Yefremov, Alex Frenkel, Diana Gaitini, Ora Israel, Rachel Bar-Shalom, Hernan Altman, Clinical Performance of PET/CT in Evaluation of Cancer: Additional Value for Diagnostic Imaging and Patient Management The Journal of Nuclear Medicine. ,vol. 44, pp. 1200- 1209 ,(2003)
J A Radford, R A Cowan, M Flanagan, G Dunn, D Crowther, R J Johnson, B Eddleston, The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. Journal of Clinical Oncology. ,vol. 6, pp. 940- 946 ,(1988) , 10.1200/JCO.1988.6.6.940
Christian Cohade, Richard L. Wahl, Karen A. Mourtzikos, "USA-Fat": prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT. The Journal of Nuclear Medicine. ,vol. 44, pp. 1267- 1270 ,(2003)
Johannes Czernin, Sanjiv S. Gambhir, Judy Schwimmer, Michael E. Phelps, R. Edward Coleman, Daniel H. S. Silverman, A Tabulated Summary of the FDG PET Literature The Journal of Nuclear Medicine. ,vol. 42, pp. 441- 441 ,(2001)
Inga Buchmann, Michael Reinhardt, Klaus Elsner, Donald Bunjes, Carsten Altehoefer, J�rgen Finke, Ernst Moser, Gerhard Glatting, J�rg Kotzerke, Carl A. Guhlmann, Holger Schirrmeister, Sven N. Reske, 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer. ,vol. 91, pp. 889- 899 ,(2001) , 10.1002/1097-0142(20010301)91:5<889::AID-CNCR1078>3.0.CO;2-5
Peter J. Ell, Gustav K. von Schulthess, PET/CT: a new road map. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 29, pp. 719- 720 ,(2002) , 10.1007/S00259-002-0844-Z
Lale Kostakoglu, John P. Leonard, Ichiei Kuji, Morton Coleman, Shankar Vallabhajosula, Stanley J. Goldsmith, Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Cancer. ,vol. 94, pp. 879- 888 ,(2002) , 10.1002/CNCR.10336